연구
교육
솔루션
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Kathrin Brenker has not added Biography.
If you are Kathrin Brenker and would like to personalize this page please email our Author Liaison for assistance.
Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.
Autoimmunity Feb, 2013 | Pubmed ID: 23039284
Max-Planck Institute for Immunobiology und Epigenetics
University of Freiburg
Kathrin Brenker1,2,3,
Kerstin Osthof1,4,
Jianying Yang1,3,
Michael Reth1,3,5
1, Max-Planck Institute for Immunobiology und Epigenetics,
2Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg,
3Centre for Biological Signaling Studies, BIOSS, University of Freiburg,
4, Albert-Ludwigs-Universität,
5Institute for Biology III (Mol. Immunology), Albert-Ludwigs-Universität
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유
